As our bodies undergo hormonal shifts during perimenopause and beyond, symptoms like hot flashes, sleep troubles and mood swings are expected. But what’s less discussed is the dryness, discomfort and ...
At her eight-month pregnancy check-up, Lizmara Figueroa met with a new doctor. As he walked out the door, he made a parting comment. “He says, ‘Oh, just so you know, you’re a carrier for (spinal ...
Please provide your email address to receive an email when new articles are posted on . I do think that complement therapy can be considered for many patients with geographic atrophy, but the risks ...
Atrophy Advisor aids in managing GA in AMD by integrating progression and lifespan estimates to guide treatment decisions. GA progression is influenced by phenotypic, demographic, and genetic factors, ...
Expert Rev of Obstet Gynecol. 2013;8(5):457-465. While treatments for vulvovaginal atrophy have often focused on the vagina, it is critical to address care for the vulvar vestibule as well. The ...
Please provide your email address to receive an email when new articles are posted on . The FDA approval of Izervay has provided a second welcomed treatment option for geographic atrophy, with good ...
Researchers from the University of Zurich and collaborating institutions published a retrospective study in the Journal of Oral Implantology evaluating long-term outcomes of two zygomatic implant ...
DelveInsight’s Geographic Atrophy Market Insightsreport includes a comprehensive understanding of current treatment practices, emerging geographic atrophy drugs, market share of individual therapies, ...
At her eight-month pregnancy check-up, Lizmara Figueroa met with a new doctor. As he walked out the door, he made a parting comment. “He says, ‘Oh, just so you know, you’re a carrier for (spinal ...
The Chosun Ilbo on MSN
British boy walks after world's costliest gene therapy
A 5-year-old British boy suffering from the rare disease spinal muscular atrophy (SMA) has miraculously begun to walk four years after receiving the "world’s most expensive" gene therapy. On the 31st, ...
(MENAFN- GlobeNewsWire - Nasdaq) The global optic nerve atrophy treatment market size was valued at USD 2.53 billion in 2024 and is predicted to hit around USD 5.87 billion by 2034, rising at a 8.85% ...
Ottawa, Dec. 09, 2025 (GLOBE NEWSWIRE) -- The global optic nerve atrophy treatment market size is calculated at USD 2.75 billion in 2025 and is expected to reach around USD 5.87 billion by 2034, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback